NEO NeoGenomics Inc

$10.34

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/17/2025

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.

Website: https://www.neogenomics.com

Sector
TRADE & SERVICES
Industry
SERVICES-TESTING LABORATORIES
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1077183
Address
12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS, FL, US
Valuation
Market Cap
$1.23B
P/E Ratio
nan
PEG Ratio
3.02
Price to Book
1.36
Performance
EPS
$-0.62
Dividend Yield
—
Profit Margin
-11.90%
ROE
-8.54%
Technicals
50D MA
$10.44
200D MA
$14.25
52W High
$19.11
52W Low
$8.05
Fundamentals
Shares Outstanding
129M
Target Price
$18.27
Beta
1.41

NEO EPS Estimates vs Actual

● Estimated
● Actual

NEO News & Sentiment

Oct 28, 2025 • Motley Fool SOMEWHAT-BULLISH
NeoGenomics ( NEO ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Tuesday, Oct. 28, 2025 at 8:30 a.m. ETChief Executive Officer - Anthony ZookContinue reading ...
Oct 28, 2025 • Zacks Commentary NEUTRAL
NeoGenomics ( NEO ) Surpasses Q3 Earnings and Revenue Estimates
NeoGenomics (NEO) delivered earnings and revenue surprises of +50.00% and +2.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 23, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Armata Pharmaceuticals ( ARMP ) Surges 103.2%: Is This an Indication of Further Gains?
Armata Pharmaceuticals (ARMP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Oct 16, 2025 • Zacks Commentary SOMEWHAT-BULLISH
NeoGenomics ( NEO ) Moves 6.3% Higher: Will This Strength Last?
NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Sep 17, 2025 • Benzinga NEUTRAL
NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026 - NeoGenomics ( NASDAQ:NEO )
NeoGenomics NEO is in Phase 18, the final stage of its Adhishthana Cycle on the weekly charts. After more than 850 days of consolidation, the stock shows little sign of breaking out.
Sep 06, 2025 • Benzinga NEUTRAL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO - NeoGenomics ( NASDAQ:NEO )
NEW YORK, Sept. 06, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ( "NeoGenomics" or the "Company" ) NEO. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Sentiment Snapshot

Average Sentiment Score:

0.109
50 articles with scored sentiment

Overall Sentiment:

Neutral

NEO Reported Earnings

Jul 29, 2025
Jun 30, 2025 (Pre market)
0.01 Surprise
  • Reported EPS: $0.03
  • Estimate: $0.02
  • Whisper: —
  • Surprise %: 50.0%
Apr 29, 2025
Mar 31, 2025 (Pre market)
-0.2 Surprise
  • Reported EPS: $-0.20
  • Estimate: $-0.01
  • Whisper: —
  • Surprise %: -3970.0%
Feb 18, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: 39.9%
Nov 05, 2024
Sep 30, 2024 (Pre market)
-0.15 Surprise
  • Reported EPS: $-0.14
  • Estimate: $0.01
  • Whisper: —
  • Surprise %: -1494.0%
Jul 29, 2024
Jun 30, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $0.03
  • Estimate: $-0.00
  • Whisper: —
  • Surprise %: 1404.3%
Apr 30, 2024
Mar 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.05
  • Whisper: —
  • Surprise %: 60.0%
Feb 20, 2024
Dec 31, 2023 (Post market)
0.05 Surprise
  • Reported EPS: $0.03
  • Estimate: $-0.02
  • Whisper: —
  • Surprise %: 250.0%
Nov 06, 2023
Sep 30, 2023 (Post market)
-0.08 Surprise
  • Reported EPS: $-0.15
  • Estimate: $-0.07
  • Whisper: —
  • Surprise %: -110.4%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $-0.05
  • Estimate: $-0.11
  • Whisper: —
  • Surprise %: 54.5%

Financials